User profiles for "author:Anne M Mills"
Anne M MillsUniversity of Virginia Department of Pathology Verified email at virginia.edu Cited by 2880 |
Endometrial hyperplasia
KL Ring, AM Mills, SC Modesitt - Obstetrics & Gynecology, 2022 - journals.lww.com
The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the
etiology and risk factors, histologic classification and subtypes, malignant progression risks …
etiology and risk factors, histologic classification and subtypes, malignant progression risks …
Lynch syndrome screening in the gynecologic tract: current state of the art
AM Mills, TA Longacre - The American journal of surgical …, 2016 - journals.lww.com
Lynch syndrome underlies approximately 5% of endometrial cancers and∼ 1% of ovarian
cancers. Gynecologic malignancies are often the presenting cancer in these patients …
cancers. Gynecologic malignancies are often the presenting cancer in these patients …
Endometrial hyperplasia
AM Mills, TA Longacre - Seminars in Diagnostic Pathology, 2010 - Elsevier
Endometrial hyperplasia is a heterogeneous set of pathologic lesions that range from mild,
reversible glandular proliferations to direct cancer precursors. These lesions comprise a …
reversible glandular proliferations to direct cancer precursors. These lesions comprise a …
[HTML][HTML] Whole slide imaging versus microscopy for primary diagnosis in surgical pathology: a multicenter blinded randomized noninferiority study of 1992 cases …
S Mukhopadhyay, MD Feldman, E Abels… - The American journal …, 2018 - journals.lww.com
Most prior studies of primary diagnosis in surgical pathology using whole slide imaging
(WSI) versus microscopy have focused on specific organ systems or included relatively few …
(WSI) versus microscopy have focused on specific organ systems or included relatively few …
Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer
Lynch syndrome (LS) is an autosomal dominant inherited disorder caused by germline
mutations in DNA mismatch repair (MMR) genes. Mutation carriers are at substantially …
mutations in DNA mismatch repair (MMR) genes. Mutation carriers are at substantially …
Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: guideline from the College of American Pathologists in collaboration with …
AN Bartley, AM Mills, E Konnick… - … of pathology & …, 2022 - meridian.allenpress.com
Context.—The US Food and Drug Administration (FDA) approved immune checkpoint
inhibitor therapy for patients with advanced solid tumors that have DNA mismatch repair …
inhibitor therapy for patients with advanced solid tumors that have DNA mismatch repair …
PD-L1 expression and intratumoral heterogeneity across breast cancer subtypes and stages: an assessment of 245 primary and 40 metastatic tumors
EA Dill, AA Gru, KA Atkins, LA Friedman… - The American journal …, 2017 - journals.lww.com
Tumor expression of programmed cell death ligand 1 (PD-L1) is associated with immune
evasion in a variety of malignancies, including a subset of triple-negative breast carcinomas …
evasion in a variety of malignancies, including a subset of triple-negative breast carcinomas …
Clinically relevant molecular subtypes in leiomyosarcoma
Purpose: Leiomyosarcoma is a malignant neoplasm with smooth muscle differentiation.
Little is known about its molecular heterogeneity and no targeted therapy currently exists for …
Little is known about its molecular heterogeneity and no targeted therapy currently exists for …
PD-L1 expression in mismatch repair-deficient endometrial carcinomas, including lynch syndrome-associated and MLH1 promoter hypermethylated tumors
EA Sloan, KL Ring, BC Willis… - The American journal …, 2017 - journals.lww.com
Mismatch repair (MMR)-deficient endometrial carcinomas (ECs) bearing Lynch syndrome
(LS)-associated germline mutations or sporadic MLH1 promoter hypermethylation …
(LS)-associated germline mutations or sporadic MLH1 promoter hypermethylation …
HR-HPV E6/E7 mRNA in situ hybridization: validation against PCR, DNA in situ hybridization, and p16 immunohistochemistry in 102 samples of cervical, vulvar, anal …
AM Mills, DC Dirks, MD Poulter, SE Mills… - The American journal …, 2017 - journals.lww.com
Dysregulated expression of oncogenic types of E6 and E7 is necessary for human
papillomavirus (HPV)-driven carcinogenesis. An HPV E6/E7 mRNA in situ hybridization …
papillomavirus (HPV)-driven carcinogenesis. An HPV E6/E7 mRNA in situ hybridization …